These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 33803340)
1. Pre-Diagnostic Circulating Metabolites and Colorectal Cancer Risk in the Cancer Prevention Study-II Nutrition Cohort. McCullough ML; Hodge RA; Campbell PT; Stevens VL; Wang Y Metabolites; 2021 Mar; 11(3):. PubMed ID: 33803340 [TBL] [Abstract][Full Text] [Related]
2. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638 [TBL] [Abstract][Full Text] [Related]
3. Prospective study of blood metabolites associated with colorectal cancer risk. Shu X; Xiang YB; Rothman N; Yu D; Li HL; Yang G; Cai H; Ma X; Lan Q; Gao YT; Jia W; Shu XO; Zheng W Int J Cancer; 2018 Aug; 143(3):527-534. PubMed ID: 29479691 [TBL] [Abstract][Full Text] [Related]
4. A Metabolomics Analysis of Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II. Moore SC; Mazzilli KM; Sampson JN; Matthews CE; Carter BD; Playdon MC; Wang Y; Stevens VL Metabolites; 2021 Feb; 11(2):. PubMed ID: 33578791 [TBL] [Abstract][Full Text] [Related]
5. Prospective Proteomic Study Identifies Potential Circulating Protein Biomarkers for Colorectal Cancer Risk. Sun X; Shu XO; Lan Q; Laszkowska M; Cai Q; Rothman N; Wen W; Zheng W; Shu X Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805033 [TBL] [Abstract][Full Text] [Related]
6. Lung cancer metabolomics: a pooled analysis in the Cancer Prevention Studies. Tang Z; Liang D; Deubler EL; Sarnat JA; Chow SS; Diver WR; Wang Y BMC Med; 2024 Jun; 22(1):262. PubMed ID: 38915026 [TBL] [Abstract][Full Text] [Related]
7. The Association between Serum Bilirubin Levels and Colorectal Cancer Risk: Results from the Prospective Cooperative Health Research in the Region of Augsburg (KORA) Study in Germany. Seyed Khoei N; Anton G; Peters A; Freisling H; Wagner KH Antioxidants (Basel); 2020 Sep; 9(10):. PubMed ID: 32987702 [TBL] [Abstract][Full Text] [Related]
8. A Metabolomic Signature of Obesity and Risk of Colorectal Cancer: Two Nested Case-Control Studies. Yang M; Zhu C; Du L; Huang J; Lu J; Yang J; Tong Y; Zhu M; Song C; Shen C; Dai J; Lu X; Xu Z; Li N; Ma H; Hu Z; Gu D; Jin G; Hang D; Shen H Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837854 [TBL] [Abstract][Full Text] [Related]
9. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk. Shu X; Zheng W; Yu D; Li HL; Lan Q; Yang G; Cai H; Ma X; Rothman N; Gao YT; Jia W; Xiang YB; Shu XO Int J Cancer; 2018 Nov; 143(9):2161-2167. PubMed ID: 29717485 [TBL] [Abstract][Full Text] [Related]
10. Plasma Metabolomic Profiles and Risk of Advanced and Fatal Prostate Cancer. Wang Y; Jacobs EJ; Carter BD; Gapstur SM; Stevens VL Eur Urol Oncol; 2021 Feb; 4(1):56-65. PubMed ID: 31378665 [TBL] [Abstract][Full Text] [Related]
11. Untargeted plasma metabolomics and risk of colorectal cancer-an analysis nested within a large-scale prospective cohort. Vidman L; Zheng R; Bodén S; Ribbenstedt A; Gunter MJ; Palmqvist R; Harlid S; Brunius C; Van Guelpen B Cancer Metab; 2023 Oct; 11(1):17. PubMed ID: 37849011 [TBL] [Abstract][Full Text] [Related]
13. A prospective case-cohort analysis of plasma metabolites and breast cancer risk. Stevens VL; Carter BD; Jacobs EJ; McCullough ML; Teras LR; Wang Y Breast Cancer Res; 2023 Jan; 25(1):5. PubMed ID: 36650550 [TBL] [Abstract][Full Text] [Related]
14. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363 [TBL] [Abstract][Full Text] [Related]
15. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study. Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309 [TBL] [Abstract][Full Text] [Related]
16. Dietary Inflammatory and Insulinemic Potentials, Plasma Metabolome and Risk of Colorectal Cancer. Lee DH; Jin Q; Shi N; Wang F; Bever AM; Li J; Liang L; Hu FB; Song M; Zeleznik OA; Zhang X; Joshi A; Wu K; Jeon JY; Meyerhardt JA; Chan AT; Eliassen AH; Clish CB; Clinton SK; Giovannucci EL; Tabung FK Metabolites; 2023 Jun; 13(6):. PubMed ID: 37367904 [TBL] [Abstract][Full Text] [Related]
17. Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers. Troche JR; Mayne ST; Freedman ND; Shebl FM; Guertin KA; Cross AJ; Abnet CC PLoS One; 2016; 11(3):e0150962. PubMed ID: 26967509 [TBL] [Abstract][Full Text] [Related]
18. Metabolomic Analysis of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. McClain KM; Sampson JN; Petrick JL; Mazzilli KM; Gerszten RE; Clish CB; Purdue MP; Lipworth L; Moore SC Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557227 [TBL] [Abstract][Full Text] [Related]
19. Plasma carotenoids and breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Wang Y; Gapstur SM; Gaudet MM; Furtado JD; Campos H; McCullough ML Cancer Causes Control; 2015 Sep; 26(9):1233-44. PubMed ID: 26081425 [TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]